Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K. Wrobel, Sara Najafi, Simay Ayhan, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 11, pp. 345-345
Open Access | Times Cited: 24

Showing 24 citing articles:

The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models
Romain Sigaud, Lisa Rösch, Charlotte Gatzweiler, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 3, pp. 566-579
Open Access | Times Cited: 29
A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations
Ingrid M. Saldana-Guerrero, Luis Fernando Montaño-Gutierrez, Katy Boswell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models
Charlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 849-849
Open Access | Times Cited: 23
Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
Sofia M. Saraiva, Carlha Gutiérrez-Lovera, Jeannette Martínez-Val, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Patient-derived models: Advanced tools for precision medicine in neuroblastoma
Kristina Aaltonen, Katarzyna Radke, Aleksandra Adamska, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 9
Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma
Katharina Körholz, Johannes Ridinger, Damir Krunic, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1001-1001
Open Access | Times Cited: 22
The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with Neuroblastoma
Elizabeth R. Tucker, Sally L. George, Paola Angelini, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 4, pp. 248-248
Open Access | Times Cited: 20
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma
Michael Müller, Lisa Rösch, Sara Najafi, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4476-4476
Open Access | Times Cited: 12
A synergistic interaction between HDAC‐ and PARP inhibitors in childhood tumors with chromothripsis
Umar Khalid, Milena Simović, Linda Hammann, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 4, pp. 590-606
Open Access | Times Cited: 8
The application of zebrafish patient‐derived xenograft tumor models in the development of antitumor agents
Xiang Li, Minyong Li
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 212-236
Closed Access | Times Cited: 8
Methodological advances in the discovery of novel neuroblastoma therapeutics
Miguel F. Segura, Aroa Soriano, Josep Roma, et al.
Expert Opinion on Drug Discovery (2021) Vol. 17, Iss. 2, pp. 167-179
Closed Access | Times Cited: 11
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours
Till Seiboldt, Constantia Zeiser, Duy Nguyen, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 4, pp. 763-777
Open Access | Times Cited: 1
Diverse Engraftment Capability of Neuroblastoma Cell Lines in Zebrafish Larvae
Josephine M. Lawrence, Shyang Hong Tan, Daniel C. Kim, et al.
Zebrafish (2024)
Closed Access | Times Cited: 1
Tanshinone IIA derivatives induced S-phase arrest through stabilizing c-myc G-quadruplex DNA to regulate ROS-mediated PI3K/Akt/mTOR pathway
Teng Wang, Jun Zou, Qiong Wu, et al.
European Journal of Pharmacology (2021) Vol. 912, pp. 174586-174586
Closed Access | Times Cited: 10
Patient-Derived Xenotransplant of CNS Neoplasms in Zebrafish: A Systematic Review
Beatriz Elena Sarmiento, Santiago Callegari, Kemel A. Ghotme, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1204-1204
Open Access | Times Cited: 4
Establishment of a Zebrafish Xenograft Model for in Vivo Investigation of Nasopharyngeal Carcinoma
Enyu Huang, Haofeng Huang, Longji Wu, et al.
Cell Transplantation (2022) Vol. 31, pp. 096368972211160-096368972211160
Open Access | Times Cited: 4
ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein
Lisa Rösch, Sonja Herter, Sara Najafi, et al.
Molecular Oncology (2022) Vol. 17, Iss. 1, pp. 37-58
Open Access | Times Cited: 4
EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness
Simona Cocchi, Valentina Greco, Viktoryia Sidarovich, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4795-4795
Open Access
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11
Vid Mlakar, Ina Oehme, Laurence Lesne, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Anti-ovarian cancer migration and toxicity characteristics of a platinum(IV) pro-drug with axial HDAC inhibitor ligands in zebrafish models
Salma Begum, Scheldon D. Irvin, Carol K. Cox, et al.
Investigational New Drugs (2024)
Open Access
Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft Model
Charlotte Gatzweiler, Johannes Ridinger, Simay Ayhan, et al.
Methods in molecular biology (2022), pp. 75-85
Closed Access | Times Cited: 1
Preclinical glioma models in neuro-oncology: enhancing translational research
Serena Barachini, Mariangela Morelli, Orazio Santo Santonocito, et al.
Current Opinion in Oncology (2023) Vol. 35, Iss. 6, pp. 536-542
Closed Access
Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11 phosphorylation.
Vid Mlakar, Ina Oehme, Laurence Lesne, et al.
Research Square (Research Square) (2022)
Open Access
Neuroblastoma-associated chromosomal aberrations drive cell identity loss in human neural crest via disruption of developmental regulators
Ingrid M. Saldana-Guerrero, Luis Fernando Montaño-Gutierrez, Katy Boswell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top